1. Home
  2. MTSR vs REZI Comparison

MTSR vs REZI Comparison

Compare MTSR & REZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSR
  • REZI
  • Stock Information
  • Founded
  • MTSR 2022
  • REZI 2018
  • Country
  • MTSR United States
  • REZI United States
  • Employees
  • MTSR N/A
  • REZI N/A
  • Industry
  • MTSR
  • REZI Wholesale Distributors
  • Sector
  • MTSR
  • REZI Industrials
  • Exchange
  • MTSR NYSE
  • REZI Nasdaq
  • Market Cap
  • MTSR 3.0B
  • REZI 3.1B
  • IPO Year
  • MTSR 2025
  • REZI N/A
  • Fundamental
  • Price
  • MTSR $40.47
  • REZI $24.44
  • Analyst Decision
  • MTSR Strong Buy
  • REZI Hold
  • Analyst Count
  • MTSR 6
  • REZI 1
  • Target Price
  • MTSR $55.25
  • REZI $21.00
  • AVG Volume (30 Days)
  • MTSR 803.5K
  • REZI 1.0M
  • Earning Date
  • MTSR 08-26-2025
  • REZI 08-05-2025
  • Dividend Yield
  • MTSR N/A
  • REZI N/A
  • EPS Growth
  • MTSR N/A
  • REZI N/A
  • EPS
  • MTSR N/A
  • REZI 0.30
  • Revenue
  • MTSR N/A
  • REZI $7,045,000,000.00
  • Revenue This Year
  • MTSR N/A
  • REZI $11.43
  • Revenue Next Year
  • MTSR N/A
  • REZI $3.45
  • P/E Ratio
  • MTSR N/A
  • REZI $80.87
  • Revenue Growth
  • MTSR N/A
  • REZI 14.02
  • 52 Week Low
  • MTSR $12.30
  • REZI $14.18
  • 52 Week High
  • MTSR $47.40
  • REZI $28.28
  • Technical
  • Relative Strength Index (RSI)
  • MTSR N/A
  • REZI 63.85
  • Support Level
  • MTSR N/A
  • REZI $23.91
  • Resistance Level
  • MTSR N/A
  • REZI $24.74
  • Average True Range (ATR)
  • MTSR 0.00
  • REZI 0.58
  • MACD
  • MTSR 0.00
  • REZI -0.03
  • Stochastic Oscillator
  • MTSR 0.00
  • REZI 83.43

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

About REZI Resideo Technologies Inc.

Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.

Share on Social Networks: